Selected research
Market Analysis & Forecast
Global Biomanufacturing in Bio-based Materials Market Analysis and Forecast 2026-2032
Market perspective
The global Biomanufacturing in Bio-based Materials market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Biomanufacturing in Bio-based Materials is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Biomanufacturing in Bio-based Materials is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Biomanufacturing in Bio-based Materials is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Biomanufacturing in Bio-based Materials is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Biomanufacturing in Bio-based Materials include Braskem, NatureWorks, Tate & Lyle, Fufeng Group, Meihua Group, Bloomage Biotech, Anhui BBCA Group, Lushang Freda and Total Corbion, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Biomanufacturing in Bio-based Materials, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Biomanufacturing in Bio-based Materials, also provides the revenue of main regions and countries. Of the upcoming market potential for Biomanufacturing in Bio-based Materials, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Biomanufacturing in Bio-based Materials revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biomanufacturing in Bio-based Materials market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biomanufacturing in Bio-based Materials revenue, projected growth trends, production technology, application and end-user industry.
Biomanufacturing in Bio-based Materials Segment by Company
Braskem
NatureWorks
Tate & Lyle
Fufeng Group
Meihua Group
Bloomage Biotech
Anhui BBCA Group
Lushang Freda
Total Corbion
Zhejiang Hisun Biomaterials
Pharmacosmos A/S
Danimer Scientific
Kingfa Sci.&Tech
Kewpie Corporation
Vedan Biotechnology
Giant Biogene
Contipro Inc.
Shandong Topscience Biotech
Blue Ridge Tunhe
JNC Corporation
NAGASE
CJ Bio
Bluepha
Givaudan
RWDC Industries
Toyobo
PTT MCC Biochem
TianAn Biologic Materials Co
Kaneka
Jiangsu JLand Biotech
Jiangsu Chuangjian Medical Technology
Cathay Biotech Inc.
Zhejiang Shengda Bio-Pharm
DANCHENG CAIXIN SUGAR INDUSTRY
CanSinoBIO
AMSilk GmbH
Shandong AWA Biopharm
Shandong Mimei Biotechnology
Juyou Bio-Technology
Shanghai Techwell Biopharmacieutical
Jinpu Nuoan Biotechnology
Jinyang Pharmaceutical
Ningxia Eppen Biotech
Kuraray
Shanxi Jinbo Bio-pharmaceutical
Wuhu Interferon
Evonik
TS-Biotech
Nanjing XuanKai Biotechnology
HTL Biotechnology
Biomanufacturing in Bio-based Materials Segment by Type
Polysaccharide Polymers
Protein Polymers
Polyester Polymers
Others
Biomanufacturing in Bio-based Materials Segment by Application
Food & Beverage
Daily Chemicals
Medical
Packaging
Textiles
Automotive Industry
Other
Biomanufacturing in Bio-based Materials Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomanufacturing in Bio-based Materials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biomanufacturing in Bio-based Materials and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomanufacturing in Bio-based Materials.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Biomanufacturing in Bio-based Materials in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Biomanufacturing in Bio-based Materials company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biomanufacturing in Bio-based Materials revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Polysaccharide Polymers
- Protein Polymers
- Polyester Polymers
- Others
Applications
- Food & Beverage
- Daily Chemicals
- Medical
- Packaging
- Textiles
- Automotive Industry
- Other
Companies covered
- Braskem
- NatureWorks
- Tate & Lyle
- Fufeng Group
- Meihua Group
- Bloomage Biotech
- Anhui BBCA Group
- Lushang Freda
- Total Corbion
- Zhejiang Hisun Biomaterials
- Pharmacosmos A/S
- Danimer Scientific
- Kingfa Sci.&Tech
- Kewpie Corporation
- Vedan Biotechnology
- Giant Biogene
- Contipro Inc.
- Shandong Topscience Biotech
- Blue Ridge Tunhe
- JNC Corporation
- NAGASE
- CJ Bio
- Bluepha
- Givaudan
- RWDC Industries
- Toyobo
- PTT MCC Biochem
- TianAn Biologic Materials Co
- Kaneka
- Jiangsu JLand Biotech
- Jiangsu Chuangjian Medical Technology
- Cathay Biotech Inc.
- Zhejiang Shengda Bio-Pharm
- DANCHENG CAIXIN SUGAR INDUSTRY
- CanSinoBIO
- AMSilk GmbH
- Shandong AWA Biopharm
- Shandong Mimei Biotechnology
- Juyou Bio-Technology
- Shanghai Techwell Biopharmacieutical
- Jinpu Nuoan Biotechnology
- Jinyang Pharmaceutical
- Ningxia Eppen Biotech
- Kuraray
- Shanxi Jinbo Bio-pharmaceutical
- Wuhu Interferon
- Evonik
- TS-Biotech
- Nanjing XuanKai Biotechnology
- HTL Biotechnology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Biomanufacturing in Bio-based Materials Market by Type
- 1.2.1 Global Biomanufacturing in Bio-based Materials Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Polysaccharide Polymers
- 1.2.3 Protein Polymers
- 1.2.4 Polyester Polymers
- 1.2.5 Others
- 1.3 Biomanufacturing in Bio-based Materials Market by Application
- 1.3.1 Global Biomanufacturing in Bio-based Materials Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Food & Beverage
- 1.3.3 Daily Chemicals
- 1.3.4 Medical
- 1.3.5 Packaging
- 1.3.6 Textiles
- 1.3.7 Automotive Industry
- 1.3.8 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Biomanufacturing in Bio-based Materials Market Dynamics
- 2.1 Biomanufacturing in Bio-based Materials Industry Trends
- 2.2 Biomanufacturing in Bio-based Materials Industry Drivers
- 2.3 Biomanufacturing in Bio-based Materials Industry Opportunities and Challenges
- 2.4 Biomanufacturing in Bio-based Materials Industry Restraints
3 Global Growth Perspective
- 3.1 Global Biomanufacturing in Bio-based Materials Market Perspective (2021-2032)
- 3.2 Global Biomanufacturing in Bio-based Materials Growth Trends by Region
- 3.2.1 Global Biomanufacturing in Bio-based Materials Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Biomanufacturing in Bio-based Materials Market Size by Region (2021-2026)
- 3.2.3 Global Biomanufacturing in Bio-based Materials Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Biomanufacturing in Bio-based Materials Revenue by Players
- 4.1.1 Global Biomanufacturing in Bio-based Materials Revenue by Players (2021-2026)
- 4.1.2 Global Biomanufacturing in Bio-based Materials Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Biomanufacturing in Bio-based Materials Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Biomanufacturing in Bio-based Materials Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Biomanufacturing in Bio-based Materials Key Players Headquarters & Area Served
- 4.4 Global Biomanufacturing in Bio-based Materials Players, Product Type & Application
- 4.5 Global Biomanufacturing in Bio-based Materials Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Biomanufacturing in Bio-based Materials Market CR5 and HHI
- 4.6.3 2025 Biomanufacturing in Bio-based Materials Tier 1, Tier 2, and Tier 3
5 Biomanufacturing in Bio-based Materials Market Size by Type
- 5.1 Global Biomanufacturing in Bio-based Materials Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Biomanufacturing in Bio-based Materials Revenue by Type (2021-2032)
- 5.3 Global Biomanufacturing in Bio-based Materials Revenue Market Share by Type (2021-2032)
6 Biomanufacturing in Bio-based Materials Market Size by Application
- 6.1 Global Biomanufacturing in Bio-based Materials Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Biomanufacturing in Bio-based Materials Revenue by Application (2021-2032)
- 6.3 Global Biomanufacturing in Bio-based Materials Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Braskem
- 7.1.1 Braskem Company Information
- 7.1.2 Braskem Business Overview
- 7.1.3 Braskem Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.1.4 Braskem Biomanufacturing in Bio-based Materials Product Portfolio
- 7.1.5 Braskem Recent Developments
- 7.2 NatureWorks
- 7.2.1 NatureWorks Company Information
- 7.2.2 NatureWorks Business Overview
- 7.2.3 NatureWorks Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.2.4 NatureWorks Biomanufacturing in Bio-based Materials Product Portfolio
- 7.2.5 NatureWorks Recent Developments
- 7.3 Tate & Lyle
- 7.3.1 Tate & Lyle Company Information
- 7.3.2 Tate & Lyle Business Overview
- 7.3.3 Tate & Lyle Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.3.4 Tate & Lyle Biomanufacturing in Bio-based Materials Product Portfolio
- 7.3.5 Tate & Lyle Recent Developments
- 7.4 Fufeng Group
- 7.4.1 Fufeng Group Company Information
- 7.4.2 Fufeng Group Business Overview
- 7.4.3 Fufeng Group Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.4.4 Fufeng Group Biomanufacturing in Bio-based Materials Product Portfolio
- 7.4.5 Fufeng Group Recent Developments
- 7.5 Meihua Group
- 7.5.1 Meihua Group Company Information
- 7.5.2 Meihua Group Business Overview
- 7.5.3 Meihua Group Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.5.4 Meihua Group Biomanufacturing in Bio-based Materials Product Portfolio
- 7.5.5 Meihua Group Recent Developments
- 7.6 Bloomage Biotech
- 7.6.1 Bloomage Biotech Company Information
- 7.6.2 Bloomage Biotech Business Overview
- 7.6.3 Bloomage Biotech Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.6.4 Bloomage Biotech Biomanufacturing in Bio-based Materials Product Portfolio
- 7.6.5 Bloomage Biotech Recent Developments
- 7.7 Anhui BBCA Group
- 7.7.1 Anhui BBCA Group Company Information
- 7.7.2 Anhui BBCA Group Business Overview
- 7.7.3 Anhui BBCA Group Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.7.4 Anhui BBCA Group Biomanufacturing in Bio-based Materials Product Portfolio
- 7.7.5 Anhui BBCA Group Recent Developments
- 7.8 Lushang Freda
- 7.8.1 Lushang Freda Company Information
- 7.8.2 Lushang Freda Business Overview
- 7.8.3 Lushang Freda Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.8.4 Lushang Freda Biomanufacturing in Bio-based Materials Product Portfolio
- 7.8.5 Lushang Freda Recent Developments
- 7.9 Total Corbion
- 7.9.1 Total Corbion Company Information
- 7.9.2 Total Corbion Business Overview
- 7.9.3 Total Corbion Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.9.4 Total Corbion Biomanufacturing in Bio-based Materials Product Portfolio
- 7.9.5 Total Corbion Recent Developments
- 7.10 Zhejiang Hisun Biomaterials
- 7.10.1 Zhejiang Hisun Biomaterials Company Information
- 7.10.2 Zhejiang Hisun Biomaterials Business Overview
- 7.10.3 Zhejiang Hisun Biomaterials Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.10.4 Zhejiang Hisun Biomaterials Biomanufacturing in Bio-based Materials Product Portfolio
- 7.10.5 Zhejiang Hisun Biomaterials Recent Developments
- 7.11 Pharmacosmos A/S
- 7.11.1 Pharmacosmos A/S Company Information
- 7.11.2 Pharmacosmos A/S Business Overview
- 7.11.3 Pharmacosmos A/S Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.11.4 Pharmacosmos A/S Biomanufacturing in Bio-based Materials Product Portfolio
- 7.11.5 Pharmacosmos A/S Recent Developments
- 7.12 Danimer Scientific
- 7.12.1 Danimer Scientific Company Information
- 7.12.2 Danimer Scientific Business Overview
- 7.12.3 Danimer Scientific Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.12.4 Danimer Scientific Biomanufacturing in Bio-based Materials Product Portfolio
- 7.12.5 Danimer Scientific Recent Developments
- 7.13 Kingfa Sci.&Tech
- 7.13.1 Kingfa Sci.&Tech Company Information
- 7.13.2 Kingfa Sci.&Tech Business Overview
- 7.13.3 Kingfa Sci.&Tech Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.13.4 Kingfa Sci.&Tech Biomanufacturing in Bio-based Materials Product Portfolio
- 7.13.5 Kingfa Sci.&Tech Recent Developments
- 7.14 Kewpie Corporation
- 7.14.1 Kewpie Corporation Company Information
- 7.14.2 Kewpie Corporation Business Overview
- 7.14.3 Kewpie Corporation Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.14.4 Kewpie Corporation Biomanufacturing in Bio-based Materials Product Portfolio
- 7.14.5 Kewpie Corporation Recent Developments
- 7.15 Vedan Biotechnology
- 7.15.1 Vedan Biotechnology Company Information
- 7.15.2 Vedan Biotechnology Business Overview
- 7.15.3 Vedan Biotechnology Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.15.4 Vedan Biotechnology Biomanufacturing in Bio-based Materials Product Portfolio
- 7.15.5 Vedan Biotechnology Recent Developments
- 7.16 Giant Biogene
- 7.16.1 Giant Biogene Company Information
- 7.16.2 Giant Biogene Business Overview
- 7.16.3 Giant Biogene Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.16.4 Giant Biogene Biomanufacturing in Bio-based Materials Product Portfolio
- 7.16.5 Giant Biogene Recent Developments
- 7.17 Contipro Inc.
- 7.17.1 Contipro Inc. Company Information
- 7.17.2 Contipro Inc. Business Overview
- 7.17.3 Contipro Inc. Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.17.4 Contipro Inc. Biomanufacturing in Bio-based Materials Product Portfolio
- 7.17.5 Contipro Inc. Recent Developments
- 7.18 Shandong Topscience Biotech
- 7.18.1 Shandong Topscience Biotech Company Information
- 7.18.2 Shandong Topscience Biotech Business Overview
- 7.18.3 Shandong Topscience Biotech Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.18.4 Shandong Topscience Biotech Biomanufacturing in Bio-based Materials Product Portfolio
- 7.18.5 Shandong Topscience Biotech Recent Developments
- 7.19 Blue Ridge Tunhe
- 7.19.1 Blue Ridge Tunhe Company Information
- 7.19.2 Blue Ridge Tunhe Business Overview
- 7.19.3 Blue Ridge Tunhe Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.19.4 Blue Ridge Tunhe Biomanufacturing in Bio-based Materials Product Portfolio
- 7.19.5 Blue Ridge Tunhe Recent Developments
- 7.20 JNC Corporation
- 7.20.1 JNC Corporation Company Information
- 7.20.2 JNC Corporation Business Overview
- 7.20.3 JNC Corporation Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.20.4 JNC Corporation Biomanufacturing in Bio-based Materials Product Portfolio
- 7.20.5 JNC Corporation Recent Developments
- 7.21 NAGASE
- 7.21.1 NAGASE Company Information
- 7.21.2 NAGASE Business Overview
- 7.21.3 NAGASE Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.21.4 NAGASE Biomanufacturing in Bio-based Materials Product Portfolio
- 7.21.5 NAGASE Recent Developments
- 7.22 CJ Bio
- 7.22.1 CJ Bio Company Information
- 7.22.2 CJ Bio Business Overview
- 7.22.3 CJ Bio Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.22.4 CJ Bio Biomanufacturing in Bio-based Materials Product Portfolio
- 7.22.5 CJ Bio Recent Developments
- 7.23 Bluepha
- 7.23.1 Bluepha Company Information
- 7.23.2 Bluepha Business Overview
- 7.23.3 Bluepha Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.23.4 Bluepha Biomanufacturing in Bio-based Materials Product Portfolio
- 7.23.5 Bluepha Recent Developments
- 7.24 Givaudan
- 7.24.1 Givaudan Company Information
- 7.24.2 Givaudan Business Overview
- 7.24.3 Givaudan Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.24.4 Givaudan Biomanufacturing in Bio-based Materials Product Portfolio
- 7.24.5 Givaudan Recent Developments
- 7.25 RWDC Industries
- 7.25.1 RWDC Industries Company Information
- 7.25.2 RWDC Industries Business Overview
- 7.25.3 RWDC Industries Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.25.4 RWDC Industries Biomanufacturing in Bio-based Materials Product Portfolio
- 7.25.5 RWDC Industries Recent Developments
- 7.26 Toyobo
- 7.26.1 Toyobo Company Information
- 7.26.2 Toyobo Business Overview
- 7.26.3 Toyobo Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.26.4 Toyobo Biomanufacturing in Bio-based Materials Product Portfolio
- 7.26.5 Toyobo Recent Developments
- 7.27 PTT MCC Biochem
- 7.27.1 PTT MCC Biochem Company Information
- 7.27.2 PTT MCC Biochem Business Overview
- 7.27.3 PTT MCC Biochem Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.27.4 PTT MCC Biochem Biomanufacturing in Bio-based Materials Product Portfolio
- 7.27.5 PTT MCC Biochem Recent Developments
- 7.28 TianAn Biologic Materials Co
- 7.28.1 TianAn Biologic Materials Co Company Information
- 7.28.2 TianAn Biologic Materials Co Business Overview
- 7.28.3 TianAn Biologic Materials Co Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.28.4 TianAn Biologic Materials Co Biomanufacturing in Bio-based Materials Product Portfolio
- 7.28.5 TianAn Biologic Materials Co Recent Developments
- 7.29 Kaneka
- 7.29.1 Kaneka Company Information
- 7.29.2 Kaneka Business Overview
- 7.29.3 Kaneka Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.29.4 Kaneka Biomanufacturing in Bio-based Materials Product Portfolio
- 7.29.5 Kaneka Recent Developments
- 7.30 Jiangsu JLand Biotech
- 7.30.1 Jiangsu JLand Biotech Company Information
- 7.30.2 Jiangsu JLand Biotech Business Overview
- 7.30.3 Jiangsu JLand Biotech Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.30.4 Jiangsu JLand Biotech Biomanufacturing in Bio-based Materials Product Portfolio
- 7.30.5 Jiangsu JLand Biotech Recent Developments
- 7.31 Jiangsu Chuangjian Medical Technology
- 7.31.1 Jiangsu Chuangjian Medical Technology Company Information
- 7.31.2 Jiangsu Chuangjian Medical Technology Business Overview
- 7.31.3 Jiangsu Chuangjian Medical Technology Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.31.4 Jiangsu Chuangjian Medical Technology Biomanufacturing in Bio-based Materials Product Portfolio
- 7.31.5 Jiangsu Chuangjian Medical Technology Recent Developments
- 7.32 Cathay Biotech Inc.
- 7.32.1 Cathay Biotech Inc. Company Information
- 7.32.2 Cathay Biotech Inc. Business Overview
- 7.32.3 Cathay Biotech Inc. Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.32.4 Cathay Biotech Inc. Biomanufacturing in Bio-based Materials Product Portfolio
- 7.32.5 Cathay Biotech Inc. Recent Developments
- 7.33 Zhejiang Shengda Bio-Pharm
- 7.33.1 Zhejiang Shengda Bio-Pharm Company Information
- 7.33.2 Zhejiang Shengda Bio-Pharm Business Overview
- 7.33.3 Zhejiang Shengda Bio-Pharm Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.33.4 Zhejiang Shengda Bio-Pharm Biomanufacturing in Bio-based Materials Product Portfolio
- 7.33.5 Zhejiang Shengda Bio-Pharm Recent Developments
- 7.34 DANCHENG CAIXIN SUGAR INDUSTRY
- 7.34.1 DANCHENG CAIXIN SUGAR INDUSTRY Company Information
- 7.34.2 DANCHENG CAIXIN SUGAR INDUSTRY Business Overview
- 7.34.3 DANCHENG CAIXIN SUGAR INDUSTRY Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.34.4 DANCHENG CAIXIN SUGAR INDUSTRY Biomanufacturing in Bio-based Materials Product Portfolio
- 7.34.5 DANCHENG CAIXIN SUGAR INDUSTRY Recent Developments
- 7.35 CanSinoBIO
- 7.35.1 CanSinoBIO Company Information
- 7.35.2 CanSinoBIO Business Overview
- 7.35.3 CanSinoBIO Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.35.4 CanSinoBIO Biomanufacturing in Bio-based Materials Product Portfolio
- 7.35.5 CanSinoBIO Recent Developments
- 7.36 AMSilk GmbH
- 7.36.1 AMSilk GmbH Company Information
- 7.36.2 AMSilk GmbH Business Overview
- 7.36.3 AMSilk GmbH Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.36.4 AMSilk GmbH Biomanufacturing in Bio-based Materials Product Portfolio
- 7.36.5 AMSilk GmbH Recent Developments
- 7.37 Shandong AWA Biopharm
- 7.37.1 Shandong AWA Biopharm Company Information
- 7.37.2 Shandong AWA Biopharm Business Overview
- 7.37.3 Shandong AWA Biopharm Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.37.4 Shandong AWA Biopharm Biomanufacturing in Bio-based Materials Product Portfolio
- 7.37.5 Shandong AWA Biopharm Recent Developments
- 7.38 Shandong Mimei Biotechnology
- 7.38.1 Shandong Mimei Biotechnology Company Information
- 7.38.2 Shandong Mimei Biotechnology Business Overview
- 7.38.3 Shandong Mimei Biotechnology Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.38.4 Shandong Mimei Biotechnology Biomanufacturing in Bio-based Materials Product Portfolio
- 7.38.5 Shandong Mimei Biotechnology Recent Developments
- 7.39 Juyou Bio-Technology
- 7.39.1 Juyou Bio-Technology Company Information
- 7.39.2 Juyou Bio-Technology Business Overview
- 7.39.3 Juyou Bio-Technology Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.39.4 Juyou Bio-Technology Biomanufacturing in Bio-based Materials Product Portfolio
- 7.39.5 Juyou Bio-Technology Recent Developments
- 7.40 Shanghai Techwell Biopharmacieutical
- 7.40.1 Shanghai Techwell Biopharmacieutical Company Information
- 7.40.2 Shanghai Techwell Biopharmacieutical Business Overview
- 7.40.3 Shanghai Techwell Biopharmacieutical Biomanufacturing in Bio-based Materials Revenue and Gross Margin (2021-2026)
- 7.40.4 Shanghai Techwell Biopharmacieutical Biomanufacturing in Bio-based Materials Product Portfolio
- 7.40.5 Shanghai Techwell Biopharmacieutical Recent Developments
- 7.41 Jinpu Nuoan Biotechnology
- 7.42 Jinyang Pharmaceutical
- 7.43 Ningxia Eppen Biotech
- 7.44 Kuraray
- 7.45 Shanxi Jinbo Bio-pharmaceutical
- 7.46 Wuhu Interferon
- 7.47 Evonik
- 7.48 TS-Biotech
- 7.49 Nanjing XuanKai Biotechnology
- 7.50 HTL Biotechnology
8 North America
- 8.1 North America Biomanufacturing in Bio-based Materials Revenue (2021-2032)
- 8.2 North America Biomanufacturing in Bio-based Materials Revenue by Type (2021-2032)
- 8.2.1 North America Biomanufacturing in Bio-based Materials Revenue by Type (2021-2026)
- 8.2.2 North America Biomanufacturing in Bio-based Materials Revenue by Type (2027-2032)
- 8.3 North America Biomanufacturing in Bio-based Materials Revenue Share by Type (2021-2032)
- 8.4 North America Biomanufacturing in Bio-based Materials Revenue by Application (2021-2032)
- 8.4.1 North America Biomanufacturing in Bio-based Materials Revenue by Application (2021-2026)
- 8.4.2 North America Biomanufacturing in Bio-based Materials Revenue by Application (2027-2032)
- 8.5 North America Biomanufacturing in Bio-based Materials Revenue Share by Application (2021-2032)
- 8.6 North America Biomanufacturing in Bio-based Materials Revenue by Country
- 8.6.1 North America Biomanufacturing in Bio-based Materials Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Biomanufacturing in Bio-based Materials Revenue by Country (2021-2026)
- 8.6.3 North America Biomanufacturing in Bio-based Materials Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Biomanufacturing in Bio-based Materials Revenue (2021-2032)
- 9.2 Europe Biomanufacturing in Bio-based Materials Revenue by Type (2021-2032)
- 9.2.1 Europe Biomanufacturing in Bio-based Materials Revenue by Type (2021-2026)
- 9.2.2 Europe Biomanufacturing in Bio-based Materials Revenue by Type (2027-2032)
- 9.3 Europe Biomanufacturing in Bio-based Materials Revenue Share by Type (2021-2032)
- 9.4 Europe Biomanufacturing in Bio-based Materials Revenue by Application (2021-2032)
- 9.4.1 Europe Biomanufacturing in Bio-based Materials Revenue by Application (2021-2026)
- 9.4.2 Europe Biomanufacturing in Bio-based Materials Revenue by Application (2027-2032)
- 9.5 Europe Biomanufacturing in Bio-based Materials Revenue Share by Application (2021-2032)
- 9.6 Europe Biomanufacturing in Bio-based Materials Revenue by Country
- 9.6.1 Europe Biomanufacturing in Bio-based Materials Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Biomanufacturing in Bio-based Materials Revenue by Country (2021-2026)
- 9.6.3 Europe Biomanufacturing in Bio-based Materials Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Biomanufacturing in Bio-based Materials Revenue (2021-2032)
- 10.2 China Biomanufacturing in Bio-based Materials Revenue by Type (2021-2032)
- 10.2.1 China Biomanufacturing in Bio-based Materials Revenue by Type (2021-2026)
- 10.2.2 China Biomanufacturing in Bio-based Materials Revenue by Type (2027-2032)
- 10.3 China Biomanufacturing in Bio-based Materials Revenue Share by Type (2021-2032)
- 10.4 China Biomanufacturing in Bio-based Materials Revenue by Application (2021-2032)
- 10.4.1 China Biomanufacturing in Bio-based Materials Revenue by Application (2021-2026)
- 10.4.2 China Biomanufacturing in Bio-based Materials Revenue by Application (2027-2032)
- 10.5 China Biomanufacturing in Bio-based Materials Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Biomanufacturing in Bio-based Materials Revenue (2021-2032)
- 11.2 Asia Biomanufacturing in Bio-based Materials Revenue by Type (2021-2032)
- 11.2.1 Asia Biomanufacturing in Bio-based Materials Revenue by Type (2021-2026)
- 11.2.2 Asia Biomanufacturing in Bio-based Materials Revenue by Type (2027-2032)
- 11.3 Asia Biomanufacturing in Bio-based Materials Revenue Share by Type (2021-2032)
- 11.4 Asia Biomanufacturing in Bio-based Materials Revenue by Application (2021-2032)
- 11.4.1 Asia Biomanufacturing in Bio-based Materials Revenue by Application (2021-2026)
- 11.4.2 Asia Biomanufacturing in Bio-based Materials Revenue by Application (2027-2032)
- 11.5 Asia Biomanufacturing in Bio-based Materials Revenue Share by Application (2021-2032)
- 11.6 Asia Biomanufacturing in Bio-based Materials Revenue by Country
- 11.6.1 Asia Biomanufacturing in Bio-based Materials Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Biomanufacturing in Bio-based Materials Revenue by Country (2021-2026)
- 11.6.3 Asia Biomanufacturing in Bio-based Materials Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Biomanufacturing in Bio-based Materials Revenue (2021-2032)
- 12.2 SAMEA Biomanufacturing in Bio-based Materials Revenue by Type (2021-2032)
- 12.2.1 SAMEA Biomanufacturing in Bio-based Materials Revenue by Type (2021-2026)
- 12.2.2 SAMEA Biomanufacturing in Bio-based Materials Revenue by Type (2027-2032)
- 12.3 SAMEA Biomanufacturing in Bio-based Materials Revenue Share by Type (2021-2032)
- 12.4 SAMEA Biomanufacturing in Bio-based Materials Revenue by Application (2021-2032)
- 12.4.1 SAMEA Biomanufacturing in Bio-based Materials Revenue by Application (2021-2026)
- 12.4.2 SAMEA Biomanufacturing in Bio-based Materials Revenue by Application (2027-2032)
- 12.5 SAMEA Biomanufacturing in Bio-based Materials Revenue Share by Application (2021-2032)
- 12.6 SAMEA Biomanufacturing in Bio-based Materials Revenue by Country
- 12.6.1 SAMEA Biomanufacturing in Bio-based Materials Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Biomanufacturing in Bio-based Materials Revenue by Country (2021-2026)
- 12.6.3 SAMEA Biomanufacturing in Bio-based Materials Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst